Sr. Analyst, Portfolio & Development Finance (US)
CSL
About this role
The Senior Analyst, Portfolio & Development Finance at CSL Behring supports the R&D Portfolio, Development & Commercialization (PD&C) finance function by evaluating financial implications of therapeutic area and portfolio strategies. The role partners with global R&D finance leadership to inform short- and long-term financial planning and decisions that support study and portfolio goals.
Skills
Qualifications
About CSL
csl.comCSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
Recent company news
About CSL
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for CSL.
Salary
$122k – $163k
per year